Initiating long-acting injectable antipsychotics during acute admission for patients with schizophrenia – A 3-year follow-up
- 1 June 2015
- journal article
- research article
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 114 (6) , 539-545
Abstract
No abstract availableKeywords
Funding Information
- National Taiwan University Hospital (NTUH 99-S1378)
This publication has 34 references indexed in Scilit:
- Symptom Recurrence Following Intermittent Treatment in First-Episode Schizophrenia Successfully Treated for 2 YearsThe Journal of Clinical Psychiatry, 2012
- Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trialBMJ, 2010
- Diagnosing Bipolar Disorder in Children and AdolescentsThe Journal of Clinical Psychiatry, 2009
- Attitudes of patients and mental health staff to antipsychotic long-acting injections: Systematic reviewThe British Journal of Psychiatry, 2009
- Long-Acting Injectable Risperidone in the Treatment of Subjects With Recent-Onset PsychosisJournal of Clinical Psychopharmacology, 2008
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trialThe Lancet, 2008
- Guided Discontinuation Versus Maintenance Treatment in Remitted First-Episode PsychosisThe Journal of Clinical Psychiatry, 2007
- Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectableJournal of Psychopharmacology, 2005
- Adherence to MedicationNew England Journal of Medicine, 2005
- Antipsychotic depot medication and attitudes of community psychiatric nursesJournal of Psychiatric and Mental Health Nursing, 2005